Helga Erlendsdóttir

Author

Helga Erlendsdóttir

Also Known As

Erlendsdottir, Helga, Erlendsdóttir, Helga, H Erlendsdottir, H Erlendsdóttir, H. ERLENDSDOTTIR, H. Erlendsdottir, H. Erlendsdóttir, HELGA ERLENDSDOTTIR, Helga Erlendsdottir, Helga Erlendsdóttir

100

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

National University Hospital of Iceland University of Iceland Reykjavík University University of Oxford Wellcome Sanger Institute

About

Helga Erlendsdóttir is an author at National University Hospital of Iceland specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	859
2	Health Sciences	11	11	558
3	Public Health	4	4	293
4	Biochemistry	2	2	57
5	Clinical Nutrition	1	1	60

Helga Erlendsdóttir

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data Angela B. Brueggemann, Melissa J. Jansen van Rensburg, David R. Shaw, The Lancet Digital Health	2021	515
Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland Lena Rós Ásmundsdóttir, Helga Erlendsdóttir, Magnús Gottfreðsson Journal of Clinical Microbiology Diagnostic MycologyClinical MycologyDrug ResistanceClinical EpidemiologyVaginitis	2002	189
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium David R. Shaw, Raquel Abad, Zahin Amin‐Chowdhury, The Lancet Digital Health	2023	148
Molecular Epidemiology of Candidemia: Evidence of Clusters of Smoldering Nosocomial Infections Lena Rós Ásmundsdóttir, Helga Erlendsdóttir, Gunnsteinn Haraldsson, Clinical Infectious Diseases	2008	119
Nationwide Study of Candidemia, Antifungal Use, and Antifungal Drug Resistance in Iceland, 2000 to 2011 Lena Rós Ásmundsdóttir, Helga Erlendsdóttir, Magnús Gottfreðsson Journal of Clinical Microbiology Clinical MycologyDrug ResistanceFluconazole UseSteady StateClinical Epidemiology	2012	101
Stress related disorders and subsequent risk of life threatening infections: population based sibling controlled cohort study Huan Song, Katja Fall, Fang Fang, BMJ	2019	90
The Role of Antimicrobial Use in the Epidemiology of Resistant Pneumococci: A 10-Year Follow Up Vilhjalmur A. Arason, Jóhann A. Sigurdsson, Helga Erlendsdóttir, Microbial Drug Resistance Antibiotic ResistanceDrug ResistanceAntimicrobial UseAntimicrobial TherapyInfection Control	2006	76
Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014 Erla Björnsdóttir, Elisabete Martins, Helga Erlendsdóttir, Clinical Microbiology and Infection Infectious Disease EpidemiologyEpidemiological TrendHealthcare-associated InfectionClinical EpidemiologyInfection Control	2015	73
Clonal Spread of Resistant Pneumococci Despite Diminished Antimicrobial Use Vilhjalmur A. Arason, Adalsteinn Gunnlaugsson, Jóhann A. Sigurdsson, Microbial Drug Resistance Resistance RatesAntibiotic ResistanceDrug ResistancePreventive MedicineAntimicrobial Stewardship	2002	63
Impact of pH and cationic supplementation on in vitro postantibiotic effect Helga Erlendsdóttir Antimicrobial Agents and Chemotherapy NutritionAntibiotic AdjuvantEscherichia ColiAntimicrobial ChemotherapyDrug Resistance	1991	60

Page 1